Pulmonary edema is a medical
condition, in which, the fluid is accumulated in air spaces and parenchyma of
lung cells. This affects the gas exchange activity by lungs and leads to
respiratory failure. In case of severe pulmonary edema, the condition could be
life-threatening and need emergency medical treatment. The important causes
includes cardiac arrest and cardiac arrhythmia, hypertension, kidney failure,
upper airway obstruction and others. The major symptoms includes shortness of
breath, blood coughing, heavy sweating, which leads to respiratory failure and
may also cause death.
Visit Complete Report Here: http://www.marketresearchreports.biz/analysis-details/pulmonary-edema-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
The diagnosis of pulmonary edema is
possible through chest x-ray, ECG, echocardiogram, renal and liver function
tests and blood tests for electrolytes concentration. The disease is managed
through emergency management techniques, such as, proper ventilation (natural
or mechanical), antibiotics (if pulmonary edema is induced by lung infections),
loop diuretics (furosemide, bumetanide), respiratory distress agents
(morphine), and antipyretics (to minimize pains). The market of emergency
management techniques and medicaments is expected to grow in the upcoming
future. However, the disease can be prevented via use of dexamethasone and
sildenafil (to prevent high altitude hypoxia) and steady physical
activities.
Some of the key drivers propelling
the growth of global market includes, increased prevalence of cardiac attacks
and associated disorders, change in lifestyle, extensive R&D activities,
increasedawareness about cardiac arrest preventive therapies and increase in
pollution. Increased prevalence of cardiac arrest is one of the major factor
contributing to the growth of this market. According to WHO, around 17.3
million peopledieddue to cardiovascular and associated diseases in 2008 (30%
of total deaths). However, high cost of R&D and government austerity
policies are some of the key restraints, expected to hinder the growth of the
market.
Major companies and medical
research universities engaged in the development and commercialization of
therapeutic products for pulmonary edema includes Synvista Therapeutics, Inc.,
University of Heidelberg, MayoClinic, University of Oxford, and HopitauxUniversitaires
de Geneve among others.
This research report analyzes this
market depending on its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive
analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for
upcoming years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints. It
provides market projections for the coming years. It includes analysis of
recent developments in technology, Porter’s five force model analysis and
detailed profiles of top industry players. The report also includes a review
of micro and macro factors essential for the existing market players and new
entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point
analysis for changing competitive dynamics
- It provides a forward looking
perspective on different factors driving or restraining market
growth
- It provides a technological
growth map over time to understand the industry growth rate
- It provides a seven-year
forecast assessed on the basis of how the market is predicted to
grow
- It helps in understanding the
key product segments and their future
- It provides pin point analysis
of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed
business decisions by having complete insights of market and by making
in-depth analysis of market segments
- It provides distinctive
graphics and exemplified SWOT analysis of major market segments
Contact US: 
|
Office: United States
|
|
State Tower
90 State Street, Suite 700 Albany, NY 12207 United States |
No comments:
Post a Comment